SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 147 filers reported holding NEKTAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2019$0
-100.0%
25
-10.7%
0.00%
-100.0%
Q3 2018$2,000
-93.3%
28
-98.9%
0.00%
-90.0%
Q1 2014$30,000
+7.1%
2,4650.0%0.01%0.0%
Q4 2013$28,000
+7.7%
2,4650.0%0.01%0.0%
Q3 2013$26,000
-7.1%
2,4650.0%0.01%0.0%
Q2 2013$28,0002,4650.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2014
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders